User Tools

Site Tools


cardio:diuretics:chlorthalidone

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
cardio:diuretics:chlorthalidone [2026/02/15 14:59] andrew2393cnscardio:diuretics:chlorthalidone [2026/03/15 17:05] (current) – Create Chlorthalidone page wilkie
Line 1: Line 1:
-====== Albuterol (ProAir®, Ventolin®, Proventil®) ====== +====== Chlorthalidone (Hygroton®) ======<WRAP right 340px><WRAP infobox>| {{ :cardio:diuretics:chlorthalidone_structure.svg |}} |^ Chlorthalidone || Brand Names | Hygroton® || Drug Class | [[cardio:diuretics:thiazide:start|Thiazide-Like Diuretic]] || Primary Indications [[cardio:hypertension:start|Hypertension]]; Edema || Blood Pressure Effect ↓ BP (chronic) || Mortality Benefit No (BP control) || Elimination Renal || Black Box Warning No || FDA Approval | 1960 |</WRAP></WRAP>===== Overview =====Chlorthalidone is a thiazide-like diuretic that inhibits the Na-Cl cotransporter in the distal convoluted tubule. It has longer half-life and stronger BP reduction than HCTZ.<WRAP clear></WRAP>----===== Mechanism of Action =====**Primary Molecular Target**  * Na-Cl cotransporter (NCC) in distal convoluted tubule**Segment Effects** ↓ NaCl reabsorption in DCT  ↑ Ca2+ reabsorption  Mild natriuresis**Net Physiologic Outcomes**  ↓ blood pressure (long-term)  Mild diuresis  ↓ urinary calcium----===== Indications =====  * First-line hypertension (preferred thiazide-like)  Mild edema----<WRAP blackbox>===== Black Box Warning =====No black box warning.</WRAP>----<WRAP contra>===== Contraindications =====Absolute: AnuriaRelative / Caution: Gout  Hyponatremia  Hypokalemia  * Sulfonamide allergy (severe)</WRAP>----<WRAP details>===== Dosing =====Hypertension:  * 12.5–25 mg daily (typical)  Max: 50 mg dailyEdema:  * 25–100 mg daily or divided</WRAP>----<WRAP details>===== Pharmacokinetics =====Absorption:  * OralBioavailability:  * ~65%Metabolism:  * MinimalHalf-life:  * ~4060 hoursElimination:  * Renal</WRAP>----<WRAP details>===== Adverse Effects =====Common:  * Hypokalemia  Hyponatremia  Hyperuricemia  HyperglycemiaSerious:  * Severe hyponatremia  Arrhythmias from hypokalemia</WRAP>----<WRAP details>===== Drug Interactions =====Increased risk:  * Lithium (↑ levels)  NSAIDs (↓ effect)Avoid combination:  * Other QT-prolonging meds if severe hypokalemia</WRAP>----<WRAP monitoring>===== Monitoring =====Labs:  Electrolytes (Na+, K+)  Uric acid  GlucoseVitals:  Blood pressureClinical:  * Gout symptoms  * Orthostasis</WRAP>----<WRAP pearls>===== Clinical Pearls =====  * Longer half-life than HCTZ  Preferred in guidelines for BP control  Increases calcium reabsorption</WRAP>----===== Comparison Within Class =====Compared to other [[cardio:diuretics:thiazide:start|thiazide diuretics]]:  * Longer duration than HCTZ  * More potent BP lowering  Higher hypokalemia risk----===== Related =====  * [[cardio:diuretics:thiazide:start|Thiazide Diuretics]]  * [[cardio:hypertension:start|Hypertension]]  * [[cardio:diuretics:start|Diuretics]]
- +
-<WRAP right 340px> +
-<WRAP infobox> +
-^ Albuterol | {{:cardio:diuretics:albuterol-teaser.png?200|}} | +
-| Brand Names | ProAir®, Ventolin®, Proventil® | +
-| Drug Class | [[respiratory:beta2_agonists:start|Short-Acting β2 Agonist (SABA)]] | +
-| Primary Indication Acute bronchospasm | +
-Receptor Target β2 adrenergic receptor | +
-Mechanism ↑ cAMP → Bronchodilation | +
-Onset ~3–5 minutes | +
-Duration 4–6 hours | +
-Route | Inhaled (MDI, DPI, Neb) | +
-| Potassium Effect | ↓ Serum K⁺ (cellular shift) | +
-| FDA Approval | 1981 | +
-</WRAP> +
-</WRAP> +
- +
-===== Overview ===== +
- +
-Albuterol is the first-line rescue bronchodilator for acute bronchospasm in asthma and COPD. +
- +
-It provides rapid airway smooth muscle relaxation but does **not treat airway inflammation**, making it symptom reliever rather than a controller medication. +
- +
-Frequent use indicates poorly controlled disease and need for anti-inflammatory therapy such as [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]]. +
- +
-<WRAP clear></WRAP> +
- +
----- +
- +
-===== Mechanism of Action ===== +
- +
-**Receptor Activated** +
-  β2 adrenergic receptor   +
- +
-**Cellular Effects** +
-  ↑ cAMP +
-  Smooth muscle relaxation +
-  ↓ mediator release from mast cells +
-  ↑ mucociliary clearance +
- +
-**Systemic Effect** +
-  Drives potassium intracellularly +
- +
-Net effect: +
-  Rapid bronchodilation and relief of airflow obstruction +
- +
----- +
- +
-===== Indications ===== +
- +
-  Acute asthma symptoms +
-  * Exercise-induced bronchospasm prevention +
-  COPD rescue therapy +
-  * Temporary treatment of hyperkalemia +
- +
-Often used with: +
-  * [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]] +
-  * [[respiratory:antimuscarinics:start|Antimuscarinics]] +
- +
----- +
- +
-<WRAP contra> +
-===== Contraindications ===== +
- +
-Absolute: +
-  Hypersensitivity to albuterol +
- +
-Relative / Caution: +
-  Tachyarrhythmias +
-  Ischemic heart disease +
-  Hyperthyroidism +
- +
-</WRAP> +
- +
----- +
- +
-<WRAP details> +
-===== Dosing ===== +
- +
-Metered-Dose Inhaler: +
-  1–2 puffs every 4–6 hours PRN +
- +
-Nebulizer: +
-  * 2.5 mg every 4–6 hours PRN +
- +
-Exercise prevention: +
-  2 puffs 15 minutes prior to activity +
- +
-Frequent use (>2 days/week): +
-  Indicates uncontrolled asthma +
- +
-</WRAP> +
- +
----- +
- +
-<WRAP details> +
-===== Pharmacokinetics ===== +
- +
-Onset: +
-  3–5 minutes +
- +
-Peak: +
-  * ~30 minutes +
- +
-Duration: +
-  46 hours +
- +
-Elimination: +
-  Hepatic metabolism and renal excretion +
- +
-</WRAP> +
- +
----- +
- +
-<WRAP details> +
-===== Adverse Effects ===== +
- +
-Adrenergic: +
-  Tremor +
-  Tachycardia +
-  Palpitations +
-  Anxiety +
- +
-Metabolic: +
-  Hypokalemia +
-  Hyperglycemia (mild) +
- +
-Other: +
-  * Headache +
- +
-Dose dependent — more common with frequent use. +
- +
-</WRAP> +
- +
----- +
- +
-<WRAP details> +
-===== Drug Interactions ===== +
- +
-Beta-blockers: +
-  Reduced bronchodilator effect +
- +
-MAO inhibitors / stimulants: +
-  Increased tachycardia +
- +
-Diuretics: +
-  Increased hypokalemia risk +
- +
-</WRAP> +
- +
----- +
- +
-<WRAP monitoring> +
-===== Monitoring ===== +
- +
-  Rescue inhaler use frequency +
-  Symptom control +
-  Heart rate (high doses) +
-  Potassium (continuous nebs) +
- +
-</WRAP> +
- +
----- +
- +
-<WRAP pearls> +
-===== Clinical Pearls ===== +
- +
-  First drug used in asthma exacerbation +
-  Frequent use = need controller therapy +
-  Spacer significantly improves lung delivery +
-  * Nebulizer easier to inhale — not stronger +
-  * Useful temporary treatment for hyperkalemia +
- +
-</WRAP> +
- +
----- +
- +
-===== Comparison Within Class ===== +
- +
-Compared to [[respiratory:beta2_agonists:levalbuterol|Levalbuterol]]: +
-  Less selective β2 activity +
-  * More tremor/tachycardia +
-  Lower cost +
- +
-Compared to [[respiratory:beta2_agonists:formoterol|Formoterol]]: +
-  * Shorter duration +
-  * Used for rescue rather than maintenance +
- +
----- +
- +
-===== Related ===== +
- +
-  * [[respiratory:beta2_agonists:start|β2 Agonists]] +
-  * [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]] +
-  * [[respiratory:asthma|Asthma]] +
-  * [[respiratory:copd|COPD]]+
cardio/diuretics/chlorthalidone.txt · Last modified: by wilkie